Executive Profile*

Phyllis I. Gardner M.D.

AgeTotal Calculated CompensationThis person is connected to 40 board members in 5 different organizations across 10 different industries.

See Board Relationships
65$104,947

Background*

Dr. Phyllis I. Gardner, M.D., serves as a Director at Health Hero Network, Inc., Cellworks Group, Inc., Elim Biopharmaceuticals, Inc., SHINE, Inc., and MyHealthPage.com. Dr. Gardner serves as Director of Robert Bosch Healthcare Systems, Inc. She has been an Independent Director at Revance Therapeutics, Inc. since December 2006. She has been an Independent Director of Corium International, Inc., since 2007. She serves on the Board of Directors of several public and private ...

Read Full Background

Corporate Headquarters*

335 Bryant Street
Palo Alto, California 94301

United States

Phone: 650-543-1555
Fax: 650-327-9755

Board Members Memberships*

Director
2006-Present
Independent Director
2007-Present
Independent Director

Education*

BS
University of Illinois-Urbana-Champaign
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$50,000
Total Calculated Compensation$104,947
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer and President
Becton, Dickinson and Company
$1.1M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.3M
Hirotaka Nakatomi Chairman, Chief Executive Officer and Chairman of Crisis Management Committee
Hisamitsu Pharmaceutical Co., Inc.
¥126.0M
Stephen J. Farr Ph.D.Co-Founder, Chief Executive Officer, President and Director
Zogenix, Inc.
$434.9K
Konstantinos Alataris Ph.D.Chief Executive Officer, President and Director
Zosano Pharma Corporation
$105.3K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.